Edition:
United States

People: Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

22.65USD
13 Jan 2017
Change (% chg)

$0.25 (+1.12%)
Prev Close
$22.40
Open
$22.40
Day's High
$22.70
Day's Low
$22.30
Volume
135,478
Avg. Vol
275,424
52-wk High
$28.50
52-wk Low
$10.29

Reichling, Steve 

Mr. Steve Reichling is Chief Financial Officer of Accelerate Diagnostics Inc., since September 10, 2012. Prior to joining the Company, Mr. Reichling served as general manager of Spring Bioscience Corp., a subsidiary of Roche Tissue Diagnostics. From January 2003 to December 2009, Mr. Reichling held various finance, accounting and operations leadership roles at Roche Tissue Diagnostics and Ventana Medical Systems, Inc., including director of finance and operations, manager of business development finance, and head of Internal Audit and Sarbanes Oxley Compliance. From October 2002 to January 2003, Mr. Reichling was an auditor at Ernst & Young LLP. Mr. Reichling received his B.A. in accounting and entrepreneurship from the University of Arizona and is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, USD 190,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 59,381
Fiscal Year Total, USD 249,381

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Patience

124,749

Lawrence Mehren

300,000

Steve Reichling

249,381

Pete Bantock

296,203

Mark Miller

124,749

Jack Schuler

124,749
As Of  30 Dec 2015